Is there really a need for adaptation in the benefit assessment of orphan drugs?
Excellence for Market & Patient Access, Pricing and Reimbursement
Strategy, advocacy and partnering for the orphan drug industry
Visit us at our booth C2-043.
Meet us at the world's largest tech conference.
JCA, pricing and reimbursement opportunities of novel therapeutics in Europe
How to DiGA and DiPA
Webinar: Ready for market
Webinar on orphan drugs
Market Access & Pricing, Rare Diseases and ATMPs
What is digital health capable of?
Research - Develop - Collaborate - Commercialise
Gaps between theoretical assessment, practical benefit and reimbursement of gene therapies